Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria.

BACKGROUND: Fears of emerging artemisinin resistance in western Cambodia have prompted a series of clinical trials investigating whether slow responses to antimalarial treatment can be overcome by increasing doses of drug. METHODS: Patients with uncomplicated malaria were allocated 1 of 3 oral arte...

Full description

Bibliographic Details
Main Authors:	Bethell, D, Se, Y, Lon, C, Socheat, D, Saunders, D, Teja-Isavadharm, P, Khemawoot, P, Darapiseth, S, Lin, J, Sriwichai, S, Kuntawungin, W, Surasri, S, Lee, S, Sarim, S, Tyner, S, Smith, B, Fukuda, M
Format:	Journal article
Language:	English
Published:	2010

Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria.

Similar Items